FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3030277923> ?p ?o ?g. }

• W3030277923 endingPage "698" @default.
• W3030277923 startingPage "695" @default.
• W3030277923 abstract "ObjectiveTo investigate the effect and its molecular mechanism of celecoxib on anoikis resistance in non-small cell lung cancer cell line A549 induced by lung cancer surgical stress.MethodsA549 cells were cultured using cell culture plate covering poly-(2-hydroxyethyl methacrylate) HEMA. The control group, prostaglandin E2 (PGE2) treatment group, and PGE2 combined celecoxib treatment group were established. Anoikis of cells was assessed by flow cytometry after treatment for 48 h. Western blotting was used to detect the activation of mitogen extracellular kinase (MEK)/extracellular signal-regulated kinase 1/2 (ERK1/2) pathway and phosphatidylinositol 3 kinase (PI3K)/protein kinase B (Akt) pathway and the expression of apoptosis related proteins, Mcl-1 and Bim, in each group. BALB/c mice were used to simulate the surgical stress, and A549 cells were injected into the tail vein to establish the animal model of lung metastasis. Mice were divided into control group, surgery group and surgery plus celecoxib group (completely randomized grouping), the mice were killed after 4 weeks and lung metastasis was observed, and the expression of Mcl-1 and Bim in pulmonary nodules was detected by immunohistochemical method.ResultsFlow cytometry results showed that apoptosis rate of A549 cells cultured in poly-HEMA was (41.0±2.4)%, that in PGE2 treated group was (22.8±3.2)% (as compared with the control group, P=0.012), and that in the PGE2 combined with celecoxib treatment group was (36.6±2.4)% (as compared with the PGE2 group, P=0.034). The results of Western blotting showed that PGE2 could activate the MEK/ERK1/2 pathway, up-regulate the phosphorylation level of ERK1/2, and down-regulate the expression of Bim, while celecoxib could significantly inhibit the effects of PGE2. In addition, PGE2 had no obvious effect on PI3K/Akt pathway, but celecoxib could inhibit the pathway, and down-regulate the phosphorylation level of Akt and inhibit the expression of Mcl-1. Immunohistochemically, the expression level of Mcl-1 and Bim protein in the pulmonary nodules was consistent with that of experiments in vitro.ConclusionPGE2 is the main cytokine production in the surgical stress. This study shows that PGE2 has obvious effect in vitro on anoikis resistance, and celecoxib inhibits the MEK/ERK1/2 pathway and the PI3K/Akt pathway to increase the expression of pro-apoptotic protein Bim and decrease the expression of anti-apoptotic protein Mcl-1 in vitro and in vivo, which can promote anoikis to reduce lung cancer cells metastasis.Key words: Celecoxib; Non-small cell lung cancer; Surgical stress; Anoikis" @default.
• W3030277923 created "2020-06-05" @default.
• W3030277923 creator A5007322337 @default.
• W3030277923 creator A5018617806 @default.
• W3030277923 creator A5023846560 @default.
• W3030277923 creator A5046849313 @default.
• W3030277923 creator A5047970406 @default.
• W3030277923 creator A5070148419 @default.
• W3030277923 creator A5073675400 @default.
• W3030277923 creator A5077430901 @default.
• W3030277923 date "2018-04-08" @default.
• W3030277923 modified "2023-09-23" @default.
• W3030277923 title "Effect of celecoxib on anoikis resistance in non-small cell lung cancer induced by surgical stress" @default.
• W3030277923 doi "https://doi.org/10.3760/cma.j.issn.1001-9030.2018.04.030" @default.
• W3030277923 hasPublicationYear "2018" @default.
• W3030277923 type Work @default.
• W3030277923 sameAs 3030277923 @default.
• W3030277923 citedByCount "0" @default.
• W3030277923 crossrefType "journal-article" @default.
• W3030277923 hasAuthorship W3030277923A5007322337 @default.
• W3030277923 hasAuthorship W3030277923A5018617806 @default.
• W3030277923 hasAuthorship W3030277923A5023846560 @default.
• W3030277923 hasAuthorship W3030277923A5046849313 @default.
• W3030277923 hasAuthorship W3030277923A5047970406 @default.
• W3030277923 hasAuthorship W3030277923A5070148419 @default.
• W3030277923 hasAuthorship W3030277923A5073675400 @default.
• W3030277923 hasAuthorship W3030277923A5077430901 @default.
• W3030277923 hasConcept C121608353 @default.
• W3030277923 hasConcept C126322002 @default.
• W3030277923 hasConcept C152000582 @default.
• W3030277923 hasConcept C184235292 @default.
• W3030277923 hasConcept C185592680 @default.
• W3030277923 hasConcept C190283241 @default.
• W3030277923 hasConcept C2776256026 @default.
• W3030277923 hasConcept C2776467144 @default.
• W3030277923 hasConcept C2779013556 @default.
• W3030277923 hasConcept C502942594 @default.
• W3030277923 hasConcept C55493867 @default.
• W3030277923 hasConcept C71924100 @default.
• W3030277923 hasConcept C75217442 @default.
• W3030277923 hasConcept C81729549 @default.
• W3030277923 hasConcept C86554907 @default.
• W3030277923 hasConceptScore W3030277923C121608353 @default.
• W3030277923 hasConceptScore W3030277923C126322002 @default.
• W3030277923 hasConceptScore W3030277923C152000582 @default.
• W3030277923 hasConceptScore W3030277923C184235292 @default.
• W3030277923 hasConceptScore W3030277923C185592680 @default.
• W3030277923 hasConceptScore W3030277923C190283241 @default.
• W3030277923 hasConceptScore W3030277923C2776256026 @default.
• W3030277923 hasConceptScore W3030277923C2776467144 @default.
• W3030277923 hasConceptScore W3030277923C2779013556 @default.
• W3030277923 hasConceptScore W3030277923C502942594 @default.
• W3030277923 hasConceptScore W3030277923C55493867 @default.
• W3030277923 hasConceptScore W3030277923C71924100 @default.
• W3030277923 hasConceptScore W3030277923C75217442 @default.
• W3030277923 hasConceptScore W3030277923C81729549 @default.
• W3030277923 hasConceptScore W3030277923C86554907 @default.
• W3030277923 hasIssue "4" @default.
• W3030277923 hasLocation W30302779231 @default.
• W3030277923 hasOpenAccess W3030277923 @default.
• W3030277923 hasPrimaryLocation W30302779231 @default.
• W3030277923 hasRelatedWork W2109000034 @default.
• W3030277923 hasRelatedWork W226429260 @default.
• W3030277923 hasRelatedWork W2270342494 @default.
• W3030277923 hasRelatedWork W2373787822 @default.
• W3030277923 hasRelatedWork W2374263158 @default.
• W3030277923 hasRelatedWork W2376201881 @default.
• W3030277923 hasRelatedWork W2383116199 @default.
• W3030277923 hasRelatedWork W2392588825 @default.
• W3030277923 hasRelatedWork W2438501134 @default.
• W3030277923 hasRelatedWork W2792270471 @default.
• W3030277923 hasRelatedWork W2903775276 @default.
• W3030277923 hasRelatedWork W2995301258 @default.
• W3030277923 hasRelatedWork W3005133386 @default.
• W3030277923 hasRelatedWork W3029067717 @default.
• W3030277923 hasRelatedWork W3030785224 @default.
• W3030277923 hasRelatedWork W3032003820 @default.
• W3030277923 hasRelatedWork W3048978270 @default.
• W3030277923 hasRelatedWork W3106879533 @default.
• W3030277923 hasRelatedWork W3107161935 @default.
• W3030277923 hasRelatedWork W3120109347 @default.
• W3030277923 hasVolume "35" @default.
• W3030277923 isParatext "false" @default.
• W3030277923 isRetracted "false" @default.
• W3030277923 magId "3030277923" @default.
• W3030277923 workType "article" @default.